Rabbit Recombinant Monoclonal ChT1 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
GPA34, VSIG1, V-set and immunoglobulin domain-containing protein 1, Cell surface A33 antigen, Glycoprotein A34
- WB
Unknown
Western blot - Anti-VSIG1 antibody [EPR9356] (AB154186)
All lanes:
Western blot - Anti-VSIG1 antibody [EPR9356] (ab154186) at 1/1000 dilution
Lane 1:
Human stomach lysate at 10 µg
Lane 2:
Human esophagus cancer lysate at 10 µg
Lane 3:
Human ovary cancer lysate at 10 µg
Lane 4:
BxPC-3 cell lysate at 10 µg
Predicted band size: 42 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 23: PubMed35628371
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com